UniQure Wants to Sell

Gene therapy specialist uniQure is considering selling up amid interest from large pharma buyers. Our President & CEO. Jesse John Francis Clark, thinks Roche is an interested buyer as it is currently in a buying frenzy. Roche is in the middle of an acquisition with Spark. Roche wants Hemlibra to dominate the market so they are trying to buy up the gene therapy companies to prevent them from selling a superior product.


Read the ful artcile here.




Subscribe and Get Breaking News Sent to Your Inbox!

  • White Instagram Icon
  • White Facebook Icon

© 2019- 2020 HEMO TIMES IS A SUBSIDIARY OF RARE HEALTH NETWORK, LLC